Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence
NCT ID: NCT03267719
Last Updated: 2024-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2017-08-31
2018-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal CO2 Laser for Stress Incontinence
NCT04136652
Clinical and Urodynamic Effects of Minimally Laser (IncontiLaseTM) Procedure for Female Stress Urinary Incontinence
NCT02130375
Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence
NCT06136975
Laser and High Intensity Tesla Magnetic Stimulation (HITS) for Stress Urinary Incontinence (SUI)
NCT05670392
Laser Therapy and Pelvic Floor Muscle Training for Stress Urinary Incontinence
NCT07319247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laser therapy
Erbium-laser therapy will be applied
laser therapy
Transvaginal erbium-laser treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laser therapy
Transvaginal erbium-laser treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mixed urine incontinence with predominance of the stress component
* written informed consent
Exclusion Criteria
* patients treated radiotherapy in the small basin
* connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome)
* patient with or after malignant disease of the uterus, ovaries, vagina and vulva
* former surgery due to stress incontinence (except for the patients who had a TVT insert with removal of the TVT)
* Descensus genitalis\> POPQ Stage 1
* former surgery due to a genital lowering with vaginal netting
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christl Reisenauer, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Women's Hospital Tübingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department for Women's Health
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uro-Laser
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.